Product Information

CLOBAZAM 20 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3762 per EA under NDC 68180015801. Its NADAC has been published 391 times since May 22, 2019.

FDA first approved this application on Dec 14, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLOBAZAM 20 MG TABLET

Clobazam
$0.3762per EA
DEA Schedule CIV

Strength

20 mg/1

NDC

68180015801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CLOBAZAM

Approval Type

Generic (ANDA)

FDA Application

ANDA210545

FDA Approved

12/14/2018

TE Code

AB

On Market Since

5/8/2019

Pharmacological Classes

Benzodiazepine
Benzodiazepines
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inducers

Price Statistics

The NADAC for CLOBAZAM 20 MG TABLET has been published 391 times since May 22, 2019, and over the history we have for it it has declined 74.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3762 per EA
All-time high$1.4581 (Jun 12, 2019)
All-time low$0.3762 (Oct 21, 2026)
52-week high$0.5144
52-week low$0.3762
Median price$0.6588
Average price$0.6994
Largest weekly change+78.0% (Aug 23, 2023)
Weeks tracked391
Tracking sinceMay 22, 2019

Price History

1W

0.0%

1M

-12.9%

3M

-17.1%

6M

-22.0%

1Y

-16.9%

3Y

-42.9%

5Y

-53.4%

All

-74.2%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLOBAZAM 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 20 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.3762 per EA (NDC 68180015801), effective Nov 11, 2026.

How has the price of CLOBAZAM 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLOBAZAM 20 MG TABLET has declined 74.2%. It has been tracked across 391 weekly CMS publications since May 22, 2019.

What are the highest and lowest recorded NADAC prices for CLOBAZAM 20 MG TABLET?

Since May 22, 2019, the NADAC for CLOBAZAM 20 MG TABLET has ranged from a low of $0.3762 (Oct 21, 2026) to a high of $1.4581 (Jun 12, 2019), with a median of $0.6588 per EA.

Are there cheaper alternatives to CLOBAZAM 20 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOBAZAM 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLOBAZAM 20 MG TABLET?

CLOBAZAM 20 MG TABLET (NDC 68180015801) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.